Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Health Economics

• Publication date

  2005-04-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1002/HEC.985PMID 15736142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016cited by this paper
• Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

  2007cited by this paper
• Expected Value of Sample Information Calculations in Medical Decision Modeling

  2004cited by this paper
• The NICE reference case requirement: more pain for what, if any, gain?

  2004cited by this paper
• Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis

  2004cited by this paper
• The use of probabilistic decision models in technology assessment

  2004cited by this paper
• The NICE reference case requirement: implications for drug manufacturers and health systems.

  2004cited by this paper
• Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.

  2003cited by this paper
• A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

  2002cited by this paper
• Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease

  2002cited by this paper
• Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.

  2002cited by this paper
• Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty

  2002cited by this paper
• NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE)

  2002cited by this paper
• The National Institute for Clinical Excellence.

  2001cited by this paper
• Health economic guidelines--similarities, differences and some implications.

  2001cited by this paper
• Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research.

  2001cited by this paper
• A BAYESIAN APPROACH TO STOCHASTIC COST-EFFECTIVENESS ANALYSIS

  2001cited by this paper
• Representing uncertainty: the role of cost-effectiveness acceptability curves.

  2001cited by this paper
• Incorporating option values into the economic evaluation of health care technologies.

  2000cited by this paper
• A Bayesian approach to stochastic cost-effectiveness analysis.

  1999cited by this paper
• The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.

  1999cited by this paper
• An economic approach to clinical trial design and research priority-setting.

  1996cited by this paper
• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care

  1994cited by this paper
• Costs, effects and C/E-ratios alongside a clinical trial.

  1994cited by this paper
• The CE Plane

  1990cited by this paper
• Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation

  1986cited by this paper
• Probabilistic Sensitivity Analysis Using Monte Carlo Simulation

  1985cited by this paper

• Cost-Effectiveness of Colorectal Cancer Screening in the Dominican Republic

  2025cites this paper
• A Pragmatic Framework for Bayesian Utility Magnitude-Based Decisions

  2025cites this paper
• Systematic review on the use of cost-benefit analysis to evaluate food environment interventions

  2025cites this paper
• What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?

  2025cites this paper
• Health economic evaluation of trans-tibial prosthetic suspension systems: a protocol for a pilot using an observational study and synthetic cohort

  2025cites this paper
• Assessing the value for money, from a policy maker perspective, of 24 randomised controlled trial designs for an online weight maintenance guided self-help intervention: an expected value of sample information analysis

  2025cites this paper
• Sensitivity analysis for uncertain linear systems: a set-membership approach

  2025cites this paper
• Economic considerations of office-based methadone as an opioid use disorder treatment option: a cost-effectiveness analysis and methodological comparison

  2025cites this paper
• Estimating pain visual analogue scale from health assessment questionnaire for rheumatoid arthritis with beta mixture models

  2025cites this paper
• Incremental Cost-Effectiveness Ratios (ICERs) and Revised Metformin Cost-Effectiveness Conclusions in the Diabetes Prevention Program/ Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Robustness of Bayesian Methods in Healthcare System Assessment: A Comprehensive Review

  2025cites this paper
• The cost-effectiveness of an online intervention to prevent dementia: Results from the Maintain Your Brain (MYB) randomised controlled trial

  2025cites this paper
• Exploring graphical approaches to assess the impact of an additional trial on a decision model via updated meta-analysis

  2025cites this paper
• A United States Medicare Population-Based Cost-Effectiveness Analysis of Cemented Stem Fixation when Treating Femoral Neck Fractures.

  2025cites this paper
• Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations

  2025cites this paper
• Comparing the Influence of Heterogeneity on Model Outcomes in Individual-Level and Cohort Simulations: An Exploratory Simulation Study.

  2025cites this paper
• Cost-utility analysis of duloxetine in osteoarthritis: from Chinese healthcare perspective

  2024cites this paper
• Conditional Approval and Value-Based Pricing for New Health Technologies

  2024cites this paper
• Uncertainty Quantification in Cost-effectiveness Analysis for Stochastic-based Infectious Disease Models: Insights from Surveillance on Lymphatic Filariasis

  2024cites this paper
• Exploring the potential cost-effectiveness of a new computerised decision support tool for identifying fetal compromise during monitored term labours: an early health economic model

  2024cites this paper
• An economic evaluation of routine hepatocellular carcinoma surveillance for high-risk patients using a novel approach to modelling competing risks

  2024cites this paper
• The PHEM-B toolbox of methods for incorporating the influences on Behaviour into Public Health Economic Models

  2024cites this paper
• Estimating the EVSI with Gaussian Approximations and Spline-Based Series Methods

  2024cites this paper
• Accurate EVSI Estimation for Nonlinear Models Using the Gaussian Approximation Method

  2024cites this paper
• Reflecting parameter uncertainty in addition to variability in constrained healthcare resource discrete event simulations: worth going the extra mile or a road to nowhere?

  2023cites this paper
• Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”

  2023cites this paper
• Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma

  2023cites this paper
• A systematic review of economic evaluations of interventions targeting childhood overweight and obesity

  2023cites this paper
• CHEERS Value of Information (CHEERS-VOI) Reporting Standards - Explanation and Elaboration.

  2023cites this paper
• Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened

  2023cites this paper
• Methodological considerations for novel approaches to covariate‐adjusted indirect treatment comparisons

  2023cites this paper
• Sensitivity Analysis in Economic Evaluations of Immuno-Oncology Drugs: A Systematic Literature Review.

  2023cites this paper
• The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations

  2023cites this paper
• Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa

  2023cites this paper
• A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework

  2023cites this paper
• Cost-Effectiveness of Screening to Identify Patients With Atrial Fibrillation: A Systematic Review.

  2023cites this paper
• Decision curve analysis: confidence intervals and hypothesis testing for net benefit

  2023cites this paper
• Economics and Precision Medicine.

  2022cites this paper
• Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention

  2022cites this paper
• Understanding bias in probabilistic analysis in model-based health economic evaluation

  2022cites this paper
• Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison

  2022cites this paper
• Cost-effectiveness analysis of the Parkinson’s KinetiGraph and clinical assessment in the management of Parkinson's disease

  2022cites this paper
• Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis.

  2022cites this paper
• Transoral incisionless fundoplication is cost-effective for treatment of gastroesophageal reflux disease

  2022cites this paper
• Cost-Effectiveness of Early Intervention in Psychosis: A Modeling Study.

  2022cites this paper
• The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis

  2022cites this paper
• The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries

  2022cites this paper
• Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect

  2022cites this paper
• The long process by which HTA became a paradigm: A longitudinal conceptual structure analysis.

  2022cites this paper
• Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies

  2022cites this paper
• Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics

  2022cites this paper
• Active Learning for Multi-way Sensitivity Analysis with Application to Disease Screening Modeling

  2022cites this paper
• Clinical and Economic Evaluation of Impella Treatment for Fulminant Myocarditis　- A Preliminary Retrospective Cohort Study in Japan.

  2022cites this paper
• Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.

  2022cites this paper
• Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis

  2022cites this paper
• Cost‐effectiveness of a policy‐based intervention to reduce melanoma and other skin cancers associated with indoor tanning

  2022cites this paper
• Saliva microRNA signature to diagnose endometriosis: A cost‐effectiveness evaluation of the Endotest®

  2022cites this paper
• A review of heath economic evaluation practice in the Netherlands: are we moving forward?

  2022cites this paper
• Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity

  2022cites this paper
• Reference Case Methods for Expert Elicitation in Health Care Decision Making

  2021cites this paper
• Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist

  2021cites this paper
• Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.

  2021cites this paper
• Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models

  2021cites this paper
• The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)

  2021cites this paper
• Cost-utility analysis of imrecoxib compared with celecoxib for patients with osteoarthritis

  2021cites this paper
• Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis

  2021influential citation
• Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial

  2021cites this paper
• Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

  2021cites this paper
• hesim: Health Economic Simulation Modeling and Decision Analysis

  2021cites this paper
• Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals

  2021cites this paper
• Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge

  2021cites this paper
• Cost‐effectiveness of a weaning food safety and hygiene programme in rural Gambia

  2021cites this paper
• The costs of bipolar disorder in the United Kingdom

  2021cites this paper
• Target estimands for population‐adjusted indirect comparisons

  2021cites this paper
• Prehospital continuous positive airway pressure for acute respiratory failure: the ACUTE feasibility RCT.

  2021cites this paper
• Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine

  2021cites this paper
• Parametric G‐computation for compatible indirect treatment comparisons with limited individual patient data

  2021cites this paper
• How Useful Are Early Economic Models? Comment on (cid:147)Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling(cid:148)

  2020cites this paper
• Methods for population adjustment with limited access to individual patient data: A review and simulation study

  2020cites this paper
• Marginalization of Regression-Adjusted Treatment Effects in Indirect Comparisons with Limited Patient-Level Data

  2020cites this paper
• Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier

  2020cites this paper
• A Bayesian Framework for Patient-Level Partitioned Survival Cost-Utility Analysis

  2020cites this paper
• A cost-effectiveness assessment of dual-mobility bearings in revision hip arthroplasty

  2020cites this paper
• Predictive-Adjusted Indirect Comparison: A Novel Method for Population Adjustment with Limited Access to Patient-Level Data

  2020cites this paper
• Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines

  2020cites this paper
• A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations

  2020cites this paper
• Comparison of the expected rewards between probabilistic and deterministic analyses in a Markov model

  2020cites this paper
• Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data

  2020cites this paper
• Cost-effectiveness of out-of-hospital continuous positive airway pressure for acute respiratory failure: decision analytic modelling using data from a feasibility trial

  2020cites this paper
• After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?

  2020cites this paper
• Methods for Population Adjustment with Limited Access to Individual Patient Data: A Simulation Study

  2020cites this paper
• The economic burden of kidney graft failure in the United States

  2020cites this paper
• A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature.

  2020cites this paper
• An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis

  2019cites this paper
• A 1‐year perspective on goal‐directed therapy in elderly with hip fracture: Secondary outcomes

  2019cites this paper
• the minimum acceptable diagnostic accuracy of non-invasive fibrosis

  2019cites this paper
• When Simple Becomes Complicated: Why Excel Should Lose its Place at the Top Table

  2019cites this paper
• Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

  2019cites this paper
• A bronchial‐airway gene‐expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost‐effectiveness analysis

  2019cites this paper
• One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit

  2019cites this paper